Close Menu

NEW YORK (GenomeWeb) – Thermo Fisher Scientific today said that has listed its Prelude LX-4 MD HPLC as a Class I medical device with the US Food and Drug Administration for general clinical use. 

The firm also said it inked a reseller agreement with Prosolia for that firm's automated sample handling and ionization source for mass spectrometry. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.